2020
Ophthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016
Chen EM, Kombo N, Teng CC, Mruthyunjaya P, Nwanyanwu K, Parikh R. Ophthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016. Ophthalmology 2020, 127: 1292-1302. PMID: 32359935, PMCID: PMC7508869, DOI: 10.1016/j.ophtha.2020.04.037.Peer-Reviewed Original ResearchConceptsOphthalmic medicationsMedication expendituresOOP expenditureLongitudinal cohort studyOverall drug expendituresUnited States populationPrescription drug spendingGlaucoma medicationsCohort studyMedication useDry eyePrescription usePrescription expendituresPrescription medicationsOOP expensesMedicationsCopayment assistancePocket expenditureOOP spendingDrug expendituresPocket spendingDrug spendingIndirect costsMEPS participantsLinear regression
2019
Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series
Kim J, Materin MA, Sznol M, Kluger H, Weiss S, Chow J, Stoessel K, Kombo N, Del Priore L, Pointdujour-Lim R. Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series. Ophthalmology 2019, 126: 1058-1062. PMID: 30735682, PMCID: PMC6933747, DOI: 10.1016/j.ophtha.2019.01.031.Peer-Reviewed Original Research
2018
Bilateral Cicatrizing Conjunctivitis in a Middle-aged Man
Apostolopoulos N, Sinard J, Kombo N. Bilateral Cicatrizing Conjunctivitis in a Middle-aged Man. JAMA Ophthalmology 2018, 136: 706-707. PMID: 29596593, DOI: 10.1001/jamaophthalmol.2017.5490.Peer-Reviewed Original Research
2016
Ocular Syphilis Presenting as Bilateral Acute Retinal Necrosis in an Immunocompetent Host.
Hussnain SA, Ketner S, Coady PA, Kombo N, Nwanyanwu K. Ocular Syphilis Presenting as Bilateral Acute Retinal Necrosis in an Immunocompetent Host. Connecticut Medicine 2016, 80: 533-536. PMID: 29772137.Peer-Reviewed Original ResearchMeSH KeywordsEye Infections, BacterialHumansImmunocompetenceMaleMiddle AgedNeurosyphilisRetinal Necrosis Syndrome, AcuteConceptsBilateral acute retinal necrosisAcute retinal necrosisOcular syphilisRetinal necrosisCases of syphilisOphthalmic testingOcular inflammationGreat masqueraderImmunocompetent hostsDiagnostic dilemmaClinical signsHigh indexSyphilisNecrosisSignsInflammationPatientsPresentingOphthalmologistsSymptomsCliniciansSuspicionThe Ex-PRESS Glaucoma Filtration Device Implantation in Uveitic Glaucoma
Dhanireddy S, Kombo NC, Payal AR, Freitas-Neto CA, Preble J, Foster CS. The Ex-PRESS Glaucoma Filtration Device Implantation in Uveitic Glaucoma. Ocular Immunology And Inflammation 2016, 25: 767-774. PMID: 27230295, DOI: 10.1080/09273948.2016.1175639.Peer-Reviewed Original ResearchConceptsIntraocular pressureUveitic glaucomaGlaucoma medicationsGlaucoma patientsSurgical successEx-PRESS implantationUveitic glaucoma patientsMean intraocular pressureEffective surgical interventionPostoperative examinationPreoperative levelsGlaucoma groupPreoperative examinationDevice implantationSurgical interventionUG groupControl groupMedicationsPatientsGlaucomaMean numberMonthsSignificant reductionEyesImplantation
2015
A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers
Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS. A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers. European Journal Of Ophthalmology 2015, 26: 30-35. PMID: 26350994, DOI: 10.5301/ejo.5000673.Peer-Reviewed Original ResearchConceptsPositive Epstein-Barr virusEpstein-Barr virusTherapeutic trialsEBV infection/reactivationInfection/reactivationMassachusetts Eye ResearchCauses of uveitisRetrospective chart reviewImmunoglobulin G titersSurgery institutionsValganciclovir therapyEBV reactivationImmunomodulatory therapyIntraocular inflammationChart reviewIgG titersPersistent inflammationEA antibodyEBV-EAG titersValganciclovirNegative studiesUveitisPatientsInflammation